317 related articles for article (PubMed ID: 31830937)
21. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
[TBL] [Abstract][Full Text] [Related]
22. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
[TBL] [Abstract][Full Text] [Related]
23. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
Pasha HF; Radwan MI; Yehia AM; Toam MM
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
[TBL] [Abstract][Full Text] [Related]
24. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.
Tang D; Liu J; Wang DR; Yu HF; Li YK; Zhang JQ
Clin Invest Med; 2011 Apr; 34(2):E88-95. PubMed ID: 21463549
[TBL] [Abstract][Full Text] [Related]
26. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma.
Strzelczyk JK; Krakowczyk Ł; Owczarek AJ
Arch Oral Biol; 2019 Feb; 98():265-272. PubMed ID: 30576962
[TBL] [Abstract][Full Text] [Related]
27. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
[TBL] [Abstract][Full Text] [Related]
28. The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients.
Yang W; Wang X; Li X; Wang M; Chen X; Wu X; Wang Y; Fan Y; Jin H
Tumour Biol; 2014 Aug; 35(8):8267-79. PubMed ID: 24852431
[TBL] [Abstract][Full Text] [Related]
29. Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.
Majchrzak-Celińska A; Słocińska M; Barciszewska AM; Nowak S; Baer-Dubowska W
J Appl Genet; 2016 May; 57(2):189-97. PubMed ID: 26337424
[TBL] [Abstract][Full Text] [Related]
30. Concurrent Hypermethylation of
Wang H; Duan XL; Qi XL; Meng L; Xu YS; Wu T; Dai PG
Mol Cells; 2017 Jan; 40(1):45-53. PubMed ID: 28152305
[TBL] [Abstract][Full Text] [Related]
31. Association between variation of circulating 25-OH vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer.
Boughanem H; Cabrera-Mulero A; Hernández-Alonso P; Clemente-Postigo M; Casanueva FF; Tinahones FJ; Morcillo S; Crujeiras AB; Macias-Gonzalez M
Clin Epigenetics; 2020 Jun; 12(1):83. PubMed ID: 32517740
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
Chim CS; Pang R; Fung TK; Choi CL; Liang R
Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
[TBL] [Abstract][Full Text] [Related]
33. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
34. [Detection of RASSF2 and sFRP1 promoter region methylation in sporadic colorectal cancer patients].
Lyu Z; Chen H; Jiang L; Zheng H; Hu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):41-4. PubMed ID: 24519048
[TBL] [Abstract][Full Text] [Related]
35. Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma.
Liu P; Shen JK; Hornicek FJ; Liu F; Duan Z
Sci Rep; 2017 May; 7(1):1580. PubMed ID: 28484252
[TBL] [Abstract][Full Text] [Related]
36. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
Xie Y; Wang F; Yu J; Zhang J; Liu Y; Li M; Qi J
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617573
[TBL] [Abstract][Full Text] [Related]
37. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
38. [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.].
Huang Y; Wei L; Sun AM; Zhao RC; Zhang J; Yang HT; Li B; Sun CJ; Ding XQ; Gao B; Zhong YQ; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):883-888. PubMed ID: 28598118
[TBL] [Abstract][Full Text] [Related]
39. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
[TBL] [Abstract][Full Text] [Related]
40. Variation risks of SFRP2 hypermethylation between precancerous disease and colorectal cancer.
Sui C; Wang G; Chen Q; Ma J
Tumour Biol; 2014 Oct; 35(10):10457-65. PubMed ID: 25053594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
